Have a feature idea you'd love to see implemented?
Let us know!
HCAT Health Catalyst Inc
Price (delayed)
$7.91
Market cap
$478.32M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.49
Enterprise value
$525.09M
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage
Highlights
HCAT's EPS is up by 45% year-on-year and by 19% since the previous quarter
The net income has grown by 41% YoY and by 18% from the previous quarter
Health Catalyst's quick ratio has plunged by 73% YoY and by 72% from the previous quarter
Health Catalyst's gross margin has decreased by 3.4% YoY
Key stats
What are the main financial stats of HCAT
Market
Valuations
Earnings
Shares outstanding
60.47M
Market cap
$478.32M
Enterprise value
$525.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.31
Price to sales (P/S)
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.75
Revenue
$299.48M
EBIT
-$91.29M
EBITDA
-$46.72M
Free cash flow
-$16.78M
Per share
Balance sheet
Liquidity
EPS
-$1.49
Free cash flow per share
-$0.28
Book value per share
$6.05
Revenue per share
$5.05
TBVPS
$7.06
Total assets
$691.72M
Total liabilities
$334.72M
Debt
$248.67M
Equity
$357M
Working capital
$58.04M
Debt to equity
0.7
Current ratio
1.18
Quick ratio
1.14
Net debt/EBITDA
-1
Margins
Efficiency
Dividend
EBITDA margin
-15.6%
Gross margin
44.9%
Net margin
-28.9%
Operating margin
-32.1%
Return on assets
-12.3%
Return on equity
-23.6%
Return on invested capital
-23.4%
Return on capital employed
-24.4%
Return on sales
-30.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCAT stock price
How has the Health Catalyst stock price performed over time
Intraday
1.02%
1 week
0.13%
1 month
5.75%
1 year
-18.71%
YTD
-14.58%
QTD
-2.83%
Financial performance
How have Health Catalyst's revenue and profit performed over time
Revenue
$299.48M
Gross profit
$134.54M
Operating income
-$95.98M
Net income
-$86.45M
Gross margin
44.9%
Net margin
-28.9%
The company's net margin rose by 44% YoY and by 19% QoQ
The net income has grown by 41% YoY and by 18% from the previous quarter
The operating margin rose by 40% YoY and by 17% QoQ
The operating income is up by 37% year-on-year and by 16% since the previous quarter
Growth
What is Health Catalyst's growth rate over time
Valuation
What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.31
P/S
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.75
HCAT's EPS is up by 45% year-on-year and by 19% since the previous quarter
HCAT's price to book (P/B) is 58% lower than its 5-year quarterly average of 3.1
The company's equity fell by 2.7% YoY
The stock's price to sales (P/S) is 69% less than its 5-year quarterly average of 5.1
The company's revenue rose by 5% YoY
Efficiency
How efficient is Health Catalyst business performance
HCAT's ROS is up by 41% year-on-year and by 18% since the previous quarter
Health Catalyst's return on assets has increased by 39% YoY and by 18% QoQ
HCAT's return on equity is up by 37% year-on-year and by 18% since the previous quarter
The ROIC has grown by 20% YoY
Dividends
What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCAT.
Financial health
How did Health Catalyst financials performed over time
HCAT's total assets is 107% greater than its total liabilities
The current ratio has plunged by 73% YoY and by 73% from the previous quarter
Health Catalyst's quick ratio has plunged by 73% YoY and by 72% from the previous quarter
The company's debt is 30% lower than its equity
The company's equity fell by 2.7% YoY
The debt to equity is up by 2.9% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.